| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), SCYX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.36M | - | - | |
| Other | 574.5K | - | - | |
| CFO | 398.5K | - | - | |
| Dir | 12.6K | - | - | |
| Dir | 12.1K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Angulo Gonzalez David | Chief Executive Officer | Buy | 108,695 | $0.00 | - | +8.7% | -42.7% | - | |
| Sep 12, 2024 | Angulo Gonzalez David | Chief Executive Officer | Buy | 20,000 | $1.37 | $27,400.00 | +4.1% | -11.9% | -16.4% | |
| Apr 26, 2022 | Taglietti Marco | Chief Executive Officer | Buy | 75,000 | $3.00 | $225,000.00 | +38.1% | -6.5% | +30.4% | |
| Apr 26, 2022 | Sukenick Scott | General Counsel | Buy | 3,500 | $3.00 | $10,500.00 | +7.0% | -6.5% | +30.4% | |
| Jan 22, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 599,000 | $7.86 | $4,705,430.71 | -25.0% | - | - | |
| Dec 21, 2020 | Tinmouth Brian Philippe | Director | Buy | 8,000 | $6.25 | $50,000.00 | New | - | - | |
| Dec 21, 2020 | Francois Eric | Chief Financial Officer | Buy | 600 | $6.25 | $3,750.00 | +5.4% | - | - | |
| Dec 21, 2020 | Angulo Gonzalez David | Chief Medical Officer | Buy | 1,600 | $6.25 | $10,000.00 | +7.2% | - | - | |
| Dec 21, 2020 | Anido Armando | Director | Buy | 5,000 | $6.25 | $31,250.00 | New | - | - | |
| Dec 21, 2020 | Gilman Steven C70 | Director | Buy | 4,000 | $6.25 | $25,000.00 | New | - | - |